MRP Capital Investments’s Pfizer PFE Stock Holding History

MRP Capital Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15M	Buy	47,847 +84	+0.2%	+$2.2K	0.85%	37
2026 Q1	$1.34M	Buy	47,763 +7,338	+18%	+$195K	1.17%	32
2025 Q4	$1.01M	Buy	40,425 +21,925	+119%	+$553K	0.84%	37
2025 Q3	$448K	Sell	18,500 -1,900	-9%	-$46.9K	0.39%	68
2025 Q2	$494K	Buy	20,400 +19,900	+3,980%	+$464K	0.34%	57
2025 Q1	$12.7K	Buy	500 +250	+100%	+$6.54K	0.01%	166
2024 Q4	$6.63K	Buy	+250	New	+$6.78K	0.01%	181
2023 Q4	–	Sell	-30,500	Closed	-$502K	–	105
2023 Q3	$502K	Buy	30,500 +3,709	+14%	+$131K	0.55%	57
2023 Q2	$983K	Sell	26,791 -975	-4%	-$38K	0.96%	34
2023 Q1	$1.13M	Buy	27,766 +11,407	+70%	+$493K	1.24%	27
2022 Q4	$838K	Buy	+16,359	New	+$784K	0.93%	35

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MRP Capital Investments's PFE Position: Q2 2026 in Review

MRP Capital Investments increased its Pfizer (PFE) stake by 0.18% in Q2 2026, buying an estimated $2.2K and bringing the position to 47,847 shares worth $1.15M. The position accounts for 0.85% of the portfolio, ranked #37.

MRP Capital Investments first reported a position in PFE in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.34M in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

MRP Capital Investments held 47,847 shares of Pfizer worth $1.15M as of Q2 2026.
MRP Capital Investments bought 84 Pfizer shares in Q2 2026, an estimated $2.2K.
Pfizer made up 0.85% of MRP Capital Investments's portfolio in Q2 2026, its #37 holding.
MRP Capital Investments first reported a position in Pfizer in Q4 2022 and has held it in 11 quarters since.
MRP Capital Investments's Pfizer position peaked at $1.34M in Q1 2026.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MRP Capital Investments's 13F filing for Q2 2026, filed 10 Aug 2026.